We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Innate Pharma | TG:IDD | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.075 | 3.65% | 2.13 | 2.11 | 2.15 | 2.13 | 2.06 | 2.06 | 491 | 20:59:22 |
RNS Number:8699Q ID Data PLC 14 October 2003 ID Data plc ("ID Data" or the "Company") Placing Further to Company's announcement on 1 August 2003, ID Data is pleased to announce that it has raised a further #1.15 million before expenses through the issue of secured convertible loan notes 2008 ("Loan Notes") to institutional investors (the "Placing"). The Placing brings the total funds raised by the Company since 1 August 2003 to #4.15 million. Peter Cox, Chief Executive, said: "This is further good news for ID Data and highlights the confidence that the City has in the Company's business model and strategy." The proceeds of the issue of Loan Notes will provide additional working capital to allow expansion of the business. Following today's issue of Loan Notes, ID Data has issued in total #3.49 million of Loan Notes to date. The Company has the authority to issue Loan Notes up to #4 million at any time prior to 31 March 2004. The summary key terms of the Loan Note are as follows: 1. The Company has the authority to issue Loan Notes with a nominal value up to #4 million at any time prior to 31 March 2004; 2. Interest is payable by the Company at 7 per cent. per annum, payable quarterly in arrears; 3. The Loan Note converts at the rate of one Ordinary Share per 5.5p nominal value of Loan Notes if issued prior to 31 August 2003 or, if issued after this date, the higher of 5.5p and the average mid-market closing price of the Company's Ordinary Shares for the preceding three trading days to the date of the issue of the Loan Note to the Loan Noteholder; 4. The Company cannot require the Loan Noteholders to convert their Loan Notes; 5. The Directors have not applied, and do not intend to apply, to the London Stock Exchange or any other recognised investment exchange for the Loan Notes to be admitted to trading; 6. The Loan Notes are transferable in amounts or integral multiples of #100; and 7. The Loan Notes are secured by a debenture issued by the Company over the assets of the Company. For further information, please contact: ID Data plc Peter Cox Tel: +44 (0) 1536 207000 enquiries@id-data.co.uk Media Enquiries: Bankside Peter Curtain / Heather Salmond Tel: +44 (0) 20 7444 4140 heather.salmond@bankside.com Notes to Editors: ID Data plc ("ID Data") is the world's seventh-largest supplier of secure-transaction systems and smart-card services to the international telephony, banking, retail, and secure-access sectors. The Company's strategy, to move from commodity products to value-added services and solutions, has created a solid platform on which to build further growth. The Company's clients include Vodafone, Nectar, Tesco, the Automobile Association, Exxon Mobil and, in Poland, the Premium Club loyalty card scheme. ID Data has formed agreements with major global corporations to facilitate rapid market development including partnerships with Toshiba and Toppan. The Company has delivered in excess of 10 million chip cards to the banking market in the UK. The Company was founded in 1988 and was listed on the AIM market of the London Stock Exchange in October 2000. www.id-data.co.uk This information is provided by RNS The company news service from the London Stock Exchange END IODMIBBTMMJBBMJ
1 Year Innate Pharma Chart |
1 Month Innate Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions